capitalinvestment

258 results found.

Top Stocks matching your search for "capital investment"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

Both went up over 100% after the r/s and before the capital raise.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 2, 2022

$HKD This stock has been an incredible opportunity... See more

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 29, 2022

Amazing positive news from the TGTX 20221229 confe... See more

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

Both went up over 100% after the r/s and before the capital raise.

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 2, 2022

$HKD This stock has been an incredible opportunity to downsize your capital for anyone who missed it!

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 29, 2022

Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.